NPC1L1 and neoplasm: Recently, drugs or compounds such as ezetimibe that target NPC1L1 protein for blocking cholesterol absorption and terbinafine that can inhibit SQLE were shown to be effective in inhibition of PCa tumor growth [9,21], thus supporting the notion that targeting the tumor aberrant cholesterol homeostasis can be an attractive option.